Search Results - Max Roessler
- Showing 1 - 3 results of 3
-
1
-
2
Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer by Peter Horak, Dietmar Pils, Griet Haller, Ingrid Pribill, Max Roessler, Sandra Tomek, Reinhard Horvat, Robert Zeillinger, Christoph Zielinski, Michael Krainer
Published 2005Artigo -
3
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell... by Markus Joerger, Joachim von Pawel, Stefanie Kraff, Jürgen R. Fischer, Wilfried Eberhardt, Thomas Gauler, Lothar Mueller, Niels Reinmuth, Martin Reck, Martin Kimmich, F. Mayer, Hans‐Georg Kopp, Dirk Behringer, Yon‐Dschun Ko, Ralf A. Hilger, Max Roessler, Charlotte Kloft, Andrea Henrich, Berta Moritz, Michael Craig Miller, Salvatore J. Salamone, Ulrich Jaehde
Published 2016Artigo
Search Tools:
Related Subjects
Biology
Gene
Genetics
Axoneme
Basal body
Cancer
Cancer cell
Cancer research
Carboplatin
Carcinogenesis
Cell biology
Centriole
Chemotherapy
Ciliogenesis
Cilium
Cisplatin
Confidence interval
DNA methylation
Demethylating agent
Dosing
Febrile neutropenia
Flagellum
Gastroenterology
Gene expression
Gene silencing
Hazard ratio
Internal medicine
Intraflagellar transport
Lung cancer
Medicine